18/06/2026 (Agence Europe) – The Medical Device Coordination Group, which brings together representatives of Member States’ competent authorities and is chaired by a representative of the European Commission, published a guidance document, on Wednesday 17 June, clarifying the move from the ‘EC REP’ symbol to ‘EU REP’ on the labelling of medical devices and in vitro diagnostic medical devices. This change concerns the identification of the authorised representative established in the European Union for manufacturers located outside it. The document specifies that this is a terminology update that does not entail any changes for the safety of devices or for manufacturers of medical devices. A five-year transition period is provided for - until 17 June 2031 - to allow manufacturers to continue using the ‘EC REP’ symbol or to adopt ‘EU REP’. See the document: https://aeur.eu/f/mf0 (NP)